Jeffrey R. Colin has wide-ranging experience litigating intellectual property matters in a variety of industries including pharmaceuticals, biotechnology, biologics, medical devices, and consumer electronics. Jeffrey has experience litigating patent infringement cases arising under the Hatch-Waxman Act and pertaining to drugs for treating various diseases including benign prostatic hyperplasia, migraines, pain, high triglycerides, acne, cold/flu, attention deficit hyperactivity disorder, irritable bowel syndrome, and hepatic encephalopathy. Jeffrey has participated in all stages of patent litigation, including formulating litigation strategy, overseeing day-to-day case management, overseeing complex e-discovery, fact and expert discovery, motion practice, trial and appeal. Jeffrey has also provided general intellectual property counseling to clients, conducted due diligence analyses, and drafted freedom to operate opinions.
- Patent litigation
- ANDA Hatch-Waxman litigation
- General IP counseling, licensing, due diligence, opinions, and inter partes review proceedings
- Trade secret litigation